Bipolar disorder arises from disrupted communication between brain regions that regulate emotion, reward, and energy, particularly the prefrontal cortex and the amygdala. Rather than a single broken molecule or gene, the condition involves overlapping failures in brain circuits, neurotransmitter signaling, immune function, and cellular energy production. These disruptions shift together in ways that push a person between depressive and manic states, and the neuroscience behind those shifts is far more layered than a simple “chemical imbalance” framing suggests.
The Fronto-Limbic Circuit and Emotional Regulation
The most consistently identified circuit problem in bipolar disorder involves the connection between the prefrontal cortex, which handles planning and impulse control, and the amygdala, which processes emotional reactions. In a healthy brain, the prefrontal cortex acts as a brake on the amygdala, keeping emotional responses proportionate. In bipolar disorder, that braking system falters. A 2025 review of circuit-level research found that dysregulation within this fronto-limbic network underpins the emotional instability seen in both manic and depressive episodes.1PubMed. Decoding neural circuit dysregulation in bipolar disorder: Toward an advanced paradigm for multidimensional cognitive, emotional, and psychomotor treatment
What makes this interesting is that the circuit behaves differently depending on the mood state. During mania, the connection between the amygdala and the anterior cingulate cortex weakens, while the amygdala simultaneously becomes more connected to frontal regions that normally oppose it during emotional tasks. In other words, the brain’s emotional alarm system and its regulatory system start working at cross-purposes.2PubMed Central. State dependent cortico-amygdala circuit dysfunction in bipolar disorder During euthymia, these patterns partially normalize, suggesting the circuit disturbance is not entirely fixed but fluctuates with mood episodes.
Beyond the fronto-limbic pathway, broader brain networks also show disruption at rest. People with bipolar disorder tend to have weakened internal connectivity within the default mode network (involved in self-referential thinking), the salience network (which decides what deserves attention), and the central executive network (which manages working memory and goal-directed thought).3PubMed Central. Altered functional activity in bipolar disorder: A comprehensive review from a large‐scale network perspective This widespread weakness in network coordination helps explain why bipolar disorder affects not just mood but also attention, decision-making, and the sense of self.
Dopamine and the Neurotransmitter Landscape
Among neurotransmitters, dopamine has gotten the most attention in bipolar research, and there is genuine evidence to back up that focus. Imaging and pharmacological studies support a model where mania involves elevated dopamine receptor availability in the striatum, a brain region central to reward and motivation. During bipolar depression, by contrast, dopamine transporter levels rise, effectively vacuuming up dopamine and reducing its signaling. The result is a kind of seesaw: too much dopamine activity in mania, too little in depression.4PubMed Central. The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment
This model is appealing, but it is not clean. One of the puzzles is that both drugs that boost dopamine and drugs that block it can sometimes improve bipolar depression. That paradox suggests other receptors and pathways are involved. The dopamine hypothesis is best understood as a piece of the story rather than the whole thing.
Glutamate and GABA, the brain’s main excitatory and inhibitory neurotransmitters, are also implicated. Brain imaging studies have repeatedly found elevated glutamate levels in people with bipolar disorder, even when they are in a stable mood state.5PubMed. Anterior cingulate Glutamate-Glutamine cycle metabolites are altered in euthymic bipolar I disorder This excess of excitatory signaling, if not adequately countered by GABA, could contribute to the neural “noise” and instability that makes the brain vulnerable to mood switches. In certain conditions, such as when bipolar disorder co-occurs with alcohol dependence, GABA levels in the anterior cingulate cortex drop substantially, which may compound the excitatory imbalance.6Translational Psychiatry. Unique prefrontal GABA and glutamate disturbances in co-occurring bipolar disorder and alcohol dependence
How Brain Structure Changes Over Time
Bipolar disorder is not only about how the brain functions in the moment but also about how it physically changes with repeated episodes. A large multicenter study of over 1,200 individuals by the ENIGMA consortium examined longitudinal structural changes and found that structural brain abnormalities in bipolar disorder are linked to the number of mood episodes a person has experienced.7PubMed. Longitudinal Structural Brain Changes in Bipolar Disorder: A Multicenter Neuroimaging Study of 1232 Individuals by the ENIGMA Bipolar Disorder Working Group
A systematic review of neuroprogression biomarkers further detailed these patterns: people with multiple episodes tend to have larger lateral ventricles and reduced gray matter volume compared to those experiencing a first episode. A positive correlation was found between the number of manic episodes and ventricle size. People with many episodes also showed decreased activation in the prefrontal cortex, orbitofrontal cortex, anterior cingulate cortex, and several subcortical structures compared to first-episode patients.8PubMed Central. Biomarkers of neuroprogression and late staging in bipolar disorder: A systematic review These findings support a staging model of bipolar disorder, where the illness becomes progressively harder on the brain with each successive episode. That has practical significance: preventing episodes is not just about comfort in the present, it may protect brain structure for the future.
BDNF and the Brain’s Repair System
Brain-derived neurotrophic factor, or BDNF, is a protein that supports the growth and survival of neurons. In bipolar disorder, BDNF levels in the blood drop during both manic and depressive episodes. A meta-analysis of 52 studies with over 6,400 participants found that BDNF was reduced to a similar extent in both mood states, while levels were not significantly different from healthy controls during euthymia.9PubMed Central. Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies The severity of symptoms tracked inversely with BDNF levels: worse episodes, lower BDNF.
This matters because BDNF promotes neuroplasticity, the brain’s ability to rewire and adapt. When BDNF drops repeatedly with each episode, the brain’s capacity for repair diminishes. Over the long term, BDNF tends to decline as the disorder progresses, potentially contributing to the structural brain changes described above.10PubMed Central. The role of BDNF as a mediator of neuroplasticity in bipolar disorder One study found that BDNF levels could distinguish bipolar patients from healthy controls with moderate accuracy, with a sensitivity around 82%, though this is not precise enough for standalone clinical diagnosis.11PubMed. Brain-derived neurotrophic factor (BDNF) and bipolar disorder
Neuroinflammation as a Persistent Background
The immune system is increasingly recognized as a player in bipolar disorder, not just during acute episodes but as a chronic low-grade presence. Elevated markers of inflammation have been detected in the blood and cerebrospinal fluid of people with bipolar disorder. Strikingly, some genetic evidence suggests these immune alterations precede the disorder itself, detectable before illness onset rather than being purely a consequence of living with the condition.12PubMed Central. Neuroinflammation in Bipolar Depression
In patients with mood-stabilized bipolar disorder, researchers found elevated levels of markers associated with monocyte and microglial activation, including MCP-1 and YKL-40 in cerebrospinal fluid. These elevations persisted after accounting for factors like age, sex, smoking, and body mass index.13PubMed Central. Monocyte and microglial activation in patients with mood-stabilized bipolar disorder Microglia are the brain’s resident immune cells, and their chronic activation can damage neurons and synapses over time. This gives neuroinflammation a plausible role in the progressive brain changes seen in later-stage bipolar disorder.
Mitochondria and Cellular Energy
Neurons are energy-hungry cells, and their power plants are mitochondria. Research has highlighted a connection between bipolar disorder and mitochondrial dysfunction, where the energy factories in cells do not operate efficiently. This inefficiency leads to a buildup of reactive oxygen species, molecules that in excess damage proteins in neuronal membranes and intracellular enzymes.14PubMed Central. The Association Among Bipolar Disorder, Mitochondrial Dysfunction, and Reactive Oxygen Species The resulting oxidative stress may contribute to cell injury and death in brain regions involved in mood regulation.
This ties into the BDNF and neuroinflammation findings in a meaningful way: mitochondrial dysfunction, oxidative stress, and chronic inflammation form a feedback loop. Damaged mitochondria produce more reactive oxygen species, which trigger inflammatory responses, which in turn impair mitochondrial function further. The brain’s repair mechanisms, partly dependent on BDNF, are fighting uphill. The convergence of these processes helps explain why bipolar disorder becomes more damaging over many episodes and why early treatment matters so much.
Genetics and the Polygenic Landscape
Bipolar disorder is highly heritable, with twin studies suggesting a genetic contribution of around 60 to 80 percent. But no single gene causes the disorder. It is polygenic, meaning many genetic variants each contribute a small increase in risk, and these variants substantially overlap with those found in other psychiatric conditions like schizophrenia and major depression.15PubMed Central. Genetic contributions to bipolar disorder: current status and future directions
Among the strongest and most replicated genetic signals is the ANK3 gene, which codes for ankyrin-G, a protein essential for proper organization of ion channels at the nodes of Ranvier in nerve fibers. A large genome-wide study found that ANK3 on chromosome 10 carried the most significant association signal for bipolar disorder, with two independent risk variants.16Nature Communications. Genome-wide association study reveals two new risk loci for bipolar disorder17PubMed Central. Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder Disruption of ankyrin-G could impair how efficiently neurons fire and communicate, connecting the genetic risk to the circuit-level dysfunction described earlier.
The same genome-wide study identified ADCY2, a gene encoding adenylate cyclase 2, as a new risk locus. Adenylate cyclase is involved in producing cyclic AMP, a key second messenger in neuronal signaling. Another new locus was found near POU3F2, a gene involved in brain development.16Nature Communications. Genome-wide association study reveals two new risk loci for bipolar disorder Each discovered gene offers a window into what goes wrong at the molecular level, but the total number of risk loci identified so far explains only a fraction of overall genetic risk. Larger studies are expected to uncover substantially more.
Circadian Rhythms and the Internal Clock
People with bipolar disorder frequently experience disrupted sleep and circadian rhythms, and this is not merely a symptom but may be part of the pathology itself. Some studies have found a delayed circadian rhythm during depressive episodes and an advanced rhythm during mania, while other research has observed circadian delay regardless of mood state. The inconsistency has led researchers to propose that circadian rhythm disruption serves as a trait marker for bipolar disorder, a persistent vulnerability rather than a transient consequence of mood episodes.18PubMed Central. Bipolar Disorder, Circadian Rhythm and Clock Genes
This has practical implications. Disrupted sleep is one of the strongest triggers for manic episodes, and therapies that stabilize circadian rhythms, such as interpersonal and social rhythm therapy, have shown benefit as adjuncts to medication. The circadian system also regulates cortisol, melatonin, and dopamine release, so disturbances in the internal clock ripple across many of the other biological systems implicated in the disorder.
What Triggers the Switch Between States
One of the most puzzling aspects of bipolar disorder is the switch, the transition from depression to mania or vice versa, sometimes happening rapidly. The neurobiology of switching is not fully understood, but several mechanisms have been proposed. One line of evidence points to impaired homeostatic regulation of catecholamines (dopamine and norepinephrine). In an experiment where catecholamine production was artificially suppressed, the treatment did not lower mood as expected but instead triggered rebound hypomanic symptoms, consistent with a signaling system that overshoots when trying to compensate for changes.19PubMed Central. The Neurobiology of the Switch Process in Bipolar Disorder: a Review
An animal model has added another piece to the puzzle. In mice with disrupted adult hippocampal neurogenesis, researchers observed a transition from depression-like behavior to a hyperactive, mania-like state over time, suggesting that damage to the brain’s capacity for generating new neurons in the hippocampus may contribute to mood switching.20PubMed Central. Manic switching from depression is affected by adult hippocampal neurogenesis These findings are still preliminary, but they reinforce the idea that the switch is not random. It reflects a brain that cannot maintain equilibrium in the face of internal perturbation.
How Bipolar Depression Differs from Unipolar Depression in the Brain
Clinically, bipolar depression and unipolar (major) depression can look similar, and misdiagnosis is common. But neuroimaging studies are beginning to reveal real differences in brain function between the two. A systematic review found that compared to unipolar depression, bipolar depression shows heightened function and increased connectivity in salience and central executive network regions, along with reduced gray matter volume in those same areas. Default mode network patterns also differed: in unipolar depression, default mode function tracked more closely with depressive symptoms, while in bipolar depression it was more associated with distractibility.21PubMed. Distinguishing between depression in bipolar disorder and unipolar depression using magnetic resonance imaging: a systematic review
Functional near-infrared spectroscopy studies have found that frontal lobe activation patterns differ between bipolar and unipolar depression, particularly in the ventrolateral prefrontal cortex.22PubMed. Differentiating between bipolar and unipolar depression using prefrontal activation patterns: Promising results from functional near infrared spectroscopy (fNIRS) findings These differences are not yet reliable enough for routine clinical use, but they point toward a future where brain-based measures could help resolve diagnostic uncertainty earlier, potentially sparing patients years of inappropriate treatment.
Stress, the HPA Axis, and Early Life Experiences
The hypothalamic-pituitary-adrenal axis, the body’s central stress-response system, tends to be overactive in bipolar disorder. But here the evidence takes an interesting turn: studies on unaffected relatives of people with bipolar disorder suggest that HPA axis dysfunction is not a genetic endophenotype of the disorder. Instead, it appears to be driven by environmental risk factors, particularly childhood trauma.23PubMed. The HPA axis in bipolar disorder: Systematic review and meta-analysis This means stress system overactivity in bipolar disorder is likely an acquired vulnerability rather than an inherited one, shaped by adverse experiences that reprogram the stress response early in development.
For people living with bipolar disorder, this underscores why stress management and trauma-informed care matter beyond general wellness advice. The stress response system is not just incidentally disrupted in the disorder; it is a conduit through which life experiences can amplify the biological vulnerabilities already present.
How Lithium Works at the Neural Level
Lithium remains the gold standard mood stabilizer, and its mechanisms of action offer a window into the neurobiology of the disorder itself. Rather than targeting a single neurotransmitter, lithium works across several signaling pathways inside neurons. It affects glycogen synthase kinase-3 beta, protein kinase C, and phosphoinositide signaling, among others. Through these pathways, lithium alters how neurons handle internal signals and how they physically restructure themselves. It promotes changes in the phosphorylation of cytoskeletal proteins, the scaffold that gives neurons their shape and connections, which may underlie its mood-stabilizing effects.24PubMed. Overview of the mechanism of action of lithium in the brain: fifty-year update
Lithium also appears to boost BDNF levels and has anti-inflammatory properties, meaning it touches on multiple layers of the neurobiology discussed throughout this article. The fact that the most effective treatment for bipolar disorder works on so many systems simultaneously speaks to the multimodal nature of the illness itself. No single biological target is sufficient to explain or treat it.
The Gut-Brain Axis in Bipolar Disorder
A newer frontier in bipolar research involves the gut microbiome. Changes in gut bacteria composition can influence neuroinflammation and mood regulation through at least two routes: signals traveling along the vagus nerve, and short-chain fatty acids produced by gut bacteria entering the bloodstream. These short-chain fatty acids stimulate gut cells to produce serotonin and GABA, boost the integrity of the blood-brain barrier, and have direct anti-inflammatory effects in the brain.25Molecular Psychiatry. Microbiota–gut–brain axis mechanisms in the complex network of bipolar disorders: potential clinical implications and translational opportunities
This area of research is still in its early stages for bipolar disorder specifically, with most findings coming from animal models or small human studies. But the plausibility is strengthened by the known inflammatory profile of the disorder and the fact that many people with bipolar disorder experience gastrointestinal complaints. Whether future interventions targeting the microbiome (probiotics, dietary changes, fecal transplantation) could meaningfully improve bipolar symptoms remains an open question, but the biological rationale for investigation is solid.
Insulin Resistance and Metabolic Overlap
Bipolar disorder carries an elevated risk of metabolic problems, and this is not entirely explained by medication side effects. In a cross-sectional study of patients with bipolar disorder, those who met criteria for insulin resistance had significantly longer illness duration, more frequent residual symptoms, higher rates of psychiatric hospitalization, and greater medication burden.26PubMed Central. Insulin Resistance in Bipolar Disorder: A Real-World Cross-Sectional Study The insulin-resistant group also had higher body mass index, higher triglycerides, lower HDL cholesterol, and less physical activity.
Whether insulin resistance worsens bipolar outcomes directly, through effects on brain energy metabolism and inflammation, or indirectly through poorer overall health, is still being sorted out. But the co-occurrence is common enough that monitoring metabolic health is now considered standard care in bipolar treatment. For patients, this means blood sugar and lipid panels are not a tangential concern but part of managing the disorder itself.
Glymphatic Clearance and Cognitive Performance
The glymphatic system is the brain’s waste-clearance mechanism, most active during sleep, that flushes metabolic byproducts from brain tissue. A study of 185 bipolar patients and 95 healthy controls measured glymphatic system activity using diffusion imaging. Overall, the average glymphatic activity level in bipolar patients was not significantly different from controls. However, within the bipolar group, those with the lowest glymphatic activity performed worst on tests of cognitive speed and impulse control.27Oxford Academic (International Journal of Neuropsychopharmacology). Role of glymphatic system function in cognitive dysfunction among patients with bipolar disorder Given that sleep disruption is a hallmark of the disorder and the glymphatic system depends on healthy sleep, this connection is logical: poor sleep may impair waste clearance, which in turn worsens the cognitive difficulties many people with bipolar disorder experience even between mood episodes.
An Evolutionary Mismatch Perspective
One provocative angle on bipolar neurobiology comes from evolutionary psychology. Bipolar disorder appears to be rare among populations that have not adopted contemporary Western lifestyles, supporting the hypothesis that the disorder arises partly from a mismatch between the environments humans evolved in and the ones they now inhabit.28PubMed Central. Bipolar disorder: An evolutionary psychoneuroimmunological approach Factors like artificial light, irregular sleep schedules, processed diets, social isolation, and chronic psychological stress are all relatively new in evolutionary terms, and each intersects with the biological systems disrupted in bipolar disorder: circadian rhythms, inflammation, gut microbiome composition, and metabolic regulation. This does not reduce the disorder to a lifestyle problem, since the genetic vulnerability is clearly present. But it suggests that many features of modern life may activate or worsen a biological predisposition that would otherwise remain dormant or milder.